Syphilis Immunoassay Diagnostic Market by Product (Analyzer, Kit & Reagent), Technology (CLIA, ELISA), End User - Global Forecast 2024-2030

Syphilis Immunoassay Diagnostic Market by Product (Analyzer, Kit & Reagent), Technology (CLIA, ELISA), End User - Global Forecast 2024-2030


The Syphilis Immunoassay Diagnostic Market size was estimated at USD 349.49 million in 2023 and expected to reach USD 378.93 million in 2024, at a CAGR 8.51% to reach USD 619.30 million by 2030.

Global Syphilis Immunoassay Diagnostic Market

FPNV Positioning Matrix

The FPNV Positioning Matrix is pivotal in evaluating the Syphilis Immunoassay Diagnostic Market. It offers a comprehensive assessment of vendors, examining key metrics related to Business Strategy and Product Satisfaction. This in-depth analysis empowers users to make well-informed decisions aligned with their requirements. Based on the evaluation, the vendors are then categorized into four distinct quadrants representing varying levels of success: Forefront (F), Pathfinder (P), Niche (N), or Vital (V).

Market Share Analysis

The Market Share Analysis is a comprehensive tool that provides an insightful and in-depth examination of the current state of vendors in the Syphilis Immunoassay Diagnostic Market. By meticulously comparing and analyzing vendor contributions in terms of overall revenue, customer base, and other key metrics, we can offer companies a greater understanding of their performance and the challenges they face when competing for market share. Additionally, this analysis provides valuable insights into the competitive nature of the sector, including factors such as accumulation, fragmentation dominance, and amalgamation traits observed over the base year period studied. With this expanded level of detail, vendors can make more informed decisions and devise effective strategies to gain a competitive edge in the market.

Key Company Profiles

The report delves into recent significant developments in the Syphilis Immunoassay Diagnostic Market, highlighting leading vendors and their innovative profiles. These include Abbott Laboratories, Becton, Dickinson and Company, Bio-Rad Laboratories, Inc., Biolytical Laboratories, bioMérieux SA, Danaher Corporation, DiaSorin S.p.A., Elitech Group, F. Hoffmann-La Roche Ltd, Fujirebio, Inc., Gold Standard Diagnostics by Eurofins Technologies, Ortho Clinical Diagnostics by Quidel Corporation, Siemens Healthineers AG, Thermo Fisher Scientific Inc., and Trinity Biotech PLC.

Market Segmentation & Coverage

This research report categorizes the Syphilis Immunoassay Diagnostic Market to forecast the revenues and analyze trends in each of the following sub-markets:

Product
Analyzer
Kit & Reagent
Technology
CLIA
ELISA
End User
Blood Bank
Diagnostic Lab
Hospital
Region
Americas
Argentina

Brazil

Canada

Mexico

United States
California

Florida

Illinois

New York

Ohio

Pennsylvania

Texas
Asia-Pacific
Australia

China

India

Indonesia

Japan

Malaysia

Philippines

Singapore

South Korea

Taiwan

Thailand

Vietnam
Europe, Middle East & Africa
Denmark

Egypt

Finland

France

Germany

Israel

Italy

Netherlands

Nigeria

Norway

Poland

Qatar

Russia

Saudi Arabia

South Africa

Spain

Sweden

Switzerland

Turkey

United Arab Emirates

United Kingdom

The report offers valuable insights on the following aspects:

1. Market Penetration: It presents comprehensive information on the market provided by key players.
2. Market Development: It delves deep into lucrative emerging markets and analyzes the penetration across mature market segments.
3. Market Diversification: It provides detailed information on new product launches, untapped geographic regions, recent developments, and investments.
4. Competitive Assessment & Intelligence: It conducts an exhaustive assessment of market shares, strategies, products, certifications, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players.
5. Product Development & Innovation: It offers intelligent insights on future technologies, R&D activities, and breakthrough product developments.

The report addresses key questions such as:

1. What is the market size and forecast of the Syphilis Immunoassay Diagnostic Market?
2. Which products, segments, applications, and areas should one consider investing in over the forecast period in the Syphilis Immunoassay Diagnostic Market?
3. What are the technology trends and regulatory frameworks in the Syphilis Immunoassay Diagnostic Market?
4. What is the market share of the leading vendors in the Syphilis Immunoassay Diagnostic Market?
5. Which modes and strategic moves are suitable for entering the Syphilis Immunoassay Diagnostic Market?

Note: PDF & Excel + Online Access - 1 Year


1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Limitations
1.7. Assumptions
1.8. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
4.1. Introduction
4.2. Syphilis Immunoassay Diagnostic Market, by Region
5. Market Insights
5.1. Market Dynamics
5.1.1. Drivers
5.1.1.1. Rise in the prevalence of the global syphilis infection caused due to unprotected sex
5.1.1.2. Government reforms targeted towards the betterment of healthcare infrastructure
5.1.1.3. Chances of mother-to-child gestational syphilis
5.1.2. Restraints
5.1.2.1. In some stages, the disease may be asymptomatic, and problems in diagnosing very early syphilis
5.1.3. Opportunities
5.1.3.1. Rising rate of abortions, stillbirth, and other abnormalities during pregnancy
5.1.3.2. Availability of rapid, automated treponemal tests and on-the-spot testing solutions
5.1.4. Challenges
5.1.4.1. Lack of awareness of syphilis immunoassay disease
5.1.4.2. The lack of skilled professionals
5.2. Market Segmentation Analysis
5.3. Market Trend Analysis
5.4. Cumulative Impact of High Inflation
5.5. Porter’s Five Forces Analysis
5.5.1. Threat of New Entrants
5.5.2. Threat of Substitutes
5.5.3. Bargaining Power of Customers
5.5.4. Bargaining Power of Suppliers
5.5.5. Industry Rivalry
5.6. Value Chain & Critical Path Analysis
5.7. Regulatory Framework
6. Syphilis Immunoassay Diagnostic Market, by Product
6.1. Introduction
6.2. Analyzer
6.3. Kit & Reagent
7. Syphilis Immunoassay Diagnostic Market, by Technology
7.1. Introduction
7.2. CLIA
7.3. ELISA
8. Syphilis Immunoassay Diagnostic Market, by End User
8.1. Introduction
8.2. Blood Bank
8.3. Diagnostic Lab
8.4. Hospital
9. Americas Syphilis Immunoassay Diagnostic Market
9.1. Introduction
9.2. Argentina
9.3. Brazil
9.4. Canada
9.5. Mexico
9.6. United States
10. Asia-Pacific Syphilis Immunoassay Diagnostic Market
10.1. Introduction
10.2. Australia
10.3. China
10.4. India
10.5. Indonesia
10.6. Japan
10.7. Malaysia
10.8. Philippines
10.9. Singapore
10.10. South Korea
10.11. Taiwan
10.12. Thailand
10.13. Vietnam
11. Europe, Middle East & Africa Syphilis Immunoassay Diagnostic Market
11.1. Introduction
11.2. Denmark
11.3. Egypt
11.4. Finland
11.5. France
11.6. Germany
11.7. Israel
11.8. Italy
11.9. Netherlands
11.10. Nigeria
11.11. Norway
11.12. Poland
11.13. Qatar
11.14. Russia
11.15. Saudi Arabia
11.16. South Africa
11.17. Spain
11.18. Sweden
11.19. Switzerland
11.20. Turkey
11.21. United Arab Emirates
11.22. United Kingdom
12. Competitive Landscape
12.1. FPNV Positioning Matrix
12.2. Market Share Analysis, By Key Player
12.3. Competitive Scenario Analysis, By Key Player
13. Competitive Portfolio
13.1. Key Company Profiles
13.1.1. Abbott Laboratories
13.1.2. Becton, Dickinson and Company
13.1.3. Bio-Rad Laboratories, Inc.
13.1.4. Biolytical Laboratories
13.1.5. bioMérieux SA
13.1.6. Danaher Corporation
13.1.7. DiaSorin S.p.A.
13.1.8. Elitech Group
13.1.9. F. Hoffmann-La Roche Ltd
13.1.10. Fujirebio, Inc.
13.1.11. Gold Standard Diagnostics by Eurofins Technologies
13.1.12. Ortho Clinical Diagnostics by Quidel Corporation
13.1.13. Siemens Healthineers AG
13.1.14. Thermo Fisher Scientific Inc.
13.1.15. Trinity Biotech PLC
13.2. Key Product Portfolio
14. Appendix
14.1. Discussion Guide
14.2. License & Pricing
FIGURE 1. SYPHILIS IMMUNOASSAY DIAGNOSTIC MARKET RESEARCH PROCESS
FIGURE 2. SYPHILIS IMMUNOASSAY DIAGNOSTIC MARKET SIZE, 2023 VS 2030
FIGURE 3. SYPHILIS IMMUNOASSAY DIAGNOSTIC MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 4. SYPHILIS IMMUNOASSAY DIAGNOSTIC MARKET SIZE, BY REGION, 2023 VS 2030 (%)
FIGURE 5. SYPHILIS IMMUNOASSAY DIAGNOSTIC MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 6. SYPHILIS IMMUNOASSAY DIAGNOSTIC MARKET DYNAMICS
FIGURE 7. SYPHILIS IMMUNOASSAY DIAGNOSTIC MARKET SIZE, BY PRODUCT, 2023 VS 2030 (%)
FIGURE 8. SYPHILIS IMMUNOASSAY DIAGNOSTIC MARKET SIZE, BY PRODUCT, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 9. SYPHILIS IMMUNOASSAY DIAGNOSTIC MARKET SIZE, BY TECHNOLOGY, 2023 VS 2030 (%)
FIGURE 10. SYPHILIS IMMUNOASSAY DIAGNOSTIC MARKET SIZE, BY TECHNOLOGY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 11. SYPHILIS IMMUNOASSAY DIAGNOSTIC MARKET SIZE, BY END USER, 2023 VS 2030 (%)
FIGURE 12. SYPHILIS IMMUNOASSAY DIAGNOSTIC MARKET SIZE, BY END USER, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 13. AMERICAS SYPHILIS IMMUNOASSAY DIAGNOSTIC MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 14. AMERICAS SYPHILIS IMMUNOASSAY DIAGNOSTIC MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 15. UNITED STATES SYPHILIS IMMUNOASSAY DIAGNOSTIC MARKET SIZE, BY STATE, 2023 VS 2030 (%)
FIGURE 16. UNITED STATES SYPHILIS IMMUNOASSAY DIAGNOSTIC MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 17. ASIA-PACIFIC SYPHILIS IMMUNOASSAY DIAGNOSTIC MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 18. ASIA-PACIFIC SYPHILIS IMMUNOASSAY DIAGNOSTIC MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 19. EUROPE, MIDDLE EAST & AFRICA SYPHILIS IMMUNOASSAY DIAGNOSTIC MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 20. EUROPE, MIDDLE EAST & AFRICA SYPHILIS IMMUNOASSAY DIAGNOSTIC MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 21. SYPHILIS IMMUNOASSAY DIAGNOSTIC MARKET, FPNV POSITIONING MATRIX, 2023
FIGURE 22. SYPHILIS IMMUNOASSAY DIAGNOSTIC MARKET SHARE, BY KEY PLAYER, 2023

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook
Cookie Settings